No abstract available
MeSH terms
-
Antineoplastic Agents, Immunological / adverse effects*
-
HLA Antigens / genetics
-
Humans
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Melanoma / drug therapy
-
Melanoma / genetics
-
Melanoma / pathology
-
Middle Aged
-
Nivolumab / adverse effects*
-
Uveitis, Anterior / chemically induced*
-
Uveomeningoencephalitic Syndrome / chemically induced*
Substances
-
Antineoplastic Agents, Immunological
-
HLA Antigens
-
Nivolumab